Conferences

Prior to start of the Second World Congress of GA68 and PRRNT the Journal of Postgraduate Medicine Education and Research at Chandigarh University was devoted to the theme of the conference "Receptor-targeted Molecular Imaging and Radionuclide Therapy: A Path to Personalized Medicine"

We will be in Chandigarh, India to cover the Congress which starts on February 28th, 2013.  If you can not join us there please enjoy the following articles which are available online.  You can also download a complete PDF of the journal from our document section.

The 1st World Congress on Gallium-68 and Peptide Receptor Radionuclide Therapy (PRRNT) took place on June 23-26, 2011 in Bad Berka, Germany. This Congress, co-organised by the Department of Nuclear Medicine/PET Center, Zentralklinik Bad Berka and the Institute of Nuclear Chemistry, Johannes Gutenberg University, Mainz, was targeted to chemists, physicians, and investigators dealing with generators, PET radiochemistry as well as molecular imaging and radionuclide therapy.

The Congress attracted over 400 participants from 53 countries coming from all 5 continents. In addition to the official programme, there were a number of social and cultural events.

The Congress organizers have provided access to audio and video recordings of the three

CCAN's annual conference was held in Long Island, New York on August 20th 2011.  The theme of the day long conference was "Multidisciplinary Approach to the Diagnosis Treatment and Monitoring of NETs." Speakers included several local oncolgists, as well as Dr, O'Dorisio from Iowa,  Dr. Delpassand from Excel Diagnostics in Houston.and Leigh Anne Burns from Ochsner Kenner's Neuroendocrine Program.  It was a full day starting with an introduction to NETs, methods of detection as common ways to

The First World Congress on Ga-68 and Peptide Receptor Radionuclide Therapy (PRRNT) was held in Bad Berka on June 23-26, 2011.  Attended by over 400 medical professional from more than 50 countries from every corner of the world.  During the two and a half day event over 80 presentations were given on the chemistry of gallium 68 (Ga68) and its production, the use  of Ga68 in imaging, and the treatment of Neuroendocrine Tumors (NETs) using Peptide Receptor RadioNuclide Thearpy (PRRNT).  The event was orginized by Prof. Dr. Richard P. Baum of Zentralklink, Bad Berka and Prof. Dr. Frank Rösch of the Institute of Nuclear Chemistry, Johannes Gutenberg University.

Subcategories